Zydus Nycomed, the joint venture company of Zydus Cadila and Nycomed, has commissioned its newly expanded API manufacturing facility at Navi Mumbai. The company is expected to start commercial production of APIs by December 2010. To start with, the plant will be manufacturing Pantoprazole, Urapidil and Lornoxicam. By 2011, the company will produce eight additional APIs.
Xcelience, a leader in formulation development and early drug development, has recently announced the inclusion of a Vector TFC-220 Roller Compactor in the GMP Manufacturing area, therefore expanding its already impressive solid oral dosage form development and manufacturing capabilities.
The Indian pharmaceutical industry will grow at double digit owing to a rise in pharmaceutical outsourcing and consolidation of highly fragmented industry, says RNCOS in its latest research report.
AdvantaPure will exhibit its high purity pharmaceutical and biopharmaceutical products at three industry trade shows this fall. AdvantaFlex(R) biopharm tubing and molded, Class VI silicone, single use systems will be the focus. Other items include silicone container closures and manifold identification solutions.
Veriteq, a Vaisala company, launches viewLinc 3.5 to aid life sciences companies seeking continuous monitoring systems specifically geared for larger enterprises.
Parallel Project Training introduces a project management training course designed to meet the specific needs for improved value for money in clinical research project
The high-purity products manufacturer expanded its operations in 2008 and recently did so again to meet the demand for its single use systems and molded components used in pharmaceutical and biopharmaceutical production. AdvantaPure converted existing space into cleanrooms for the manufacture of silicone manifolds and container closures.
A multidisciplinary team of researches specialized on Biotechnology, Biomedicine, Science and Environmental sciences, will research in new processes for the biosimilars production.
Curaxys is the new company specialized in the production of biosimilars medicines. It is an independent private company, located on the technological park of Cadiz Spain). The new venture is focuses in the development of new technological platforms.
Pharmalogical, Inc. has developed the little pink pill for the treatment and prevention of fibroadenoma: Fibrosolve. Fibrosolve has launched today, Nov. 16, 2009.
Compass Pharma Services, a pharmaceutical contract packager, recently completed a capital investment project to upgrade its contract pharmaceutical packaging capabilities to include “ISO Class 8” specifications for potent compounds.
Chris Singer, president of the International Section of the Pharmaceutical Research and Manufacturers of America, issued the following statement today on the U.S. Trade Representative’s (USTR) "Special 301" annual report to Congress, outlining the Administration’s global intellectual property agenda:
Yankee Public Relations is pleased to announce our inaugural life sciences symposium, designed to provide small and mid-sized biotechs with strategies for success in the present financial crisis. Biotech executives at public and private companies will share their experience, lessons learned and strategies for attracting investors.
Pharmaceutical companies are actively involved in the improvement of public health, all over the world, through their various access to medicine programs.
Compass Pharma Services, LLC improved customer service for pharmaceutical packaging, blister packaging, bottle filling and powder filling and other cGMP contract packaging services.NOT copy and paste the exact same top portion of your press release.
Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report which finds that the global market for the treatment of alcohol dependence will reach $304m by 2016.
Satisfied Users & 
Approved Press Releases
